Preoperative Systemic Therapy Versus Upfront Surgery in HER2-Positive Breast Cancer in the Real World

Preoperative Systemic Therapy Versus Upfront Surgery in HER2-Positive Breast Cancer in the Real World

PurposeTo compare survival in different strategies, preoperative systemic treatment versus upfront surgery, in HER2-positive early breast cancer patients in the real world.MethodsAccording to the actual upfront treatment, eligible patients from 2012 to 2015 were classified as preoperative systemic t...

Full description

Bibliographic Details
Main Authors: Xingfei Yu, Chen Wang, Yabing Zheng, Beibei Miao, Jiejie Hu, Xiying Shao, Liming Sheng, Juan Lin, Yuqin Ding, Haojun Xuan, Yingying Ding, Lijie Gong, Weiliang Feng, Chengdong Qin, Daobao Chen, Yang Yu, Hongjian Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
human epidermal growth factor receptor 2
breast cancer
preoperative systemic treatment
surgery
real world
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.704842/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.704842/full

Similar Items